Confluent (CFLT) director reports option exercise and sale of 62,500 shares
Rhea-AI Filing Summary
A Confluent, Inc. director reported option exercises, share conversions and a planned stock sale. On 12/10/2025, the director exercised stock options for 62,500 shares of Class B Common Stock at $19.95 per share, which are convertible into Class A Common Stock on a one-for-one basis.
On the same date, 62,500 shares of Class A Common Stock were acquired through conversion and 62,500 Class A shares were sold under a Rule 10b5-1 trading plan dated March 13, 2025 at prices ranging from $30.00 to $30.005 per share. After these transactions, the director directly owned 28,549 shares of Class A Common Stock and 187,500 derivative securities.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did a Confluent (CFLT) director report?
A Confluent director reported exercising stock options for 62,500 shares of Class B Common Stock, converting shares into Class A Common Stock, and selling 62,500 Class A shares on 12/10/2025.
How many Confluent (CFLT) Class A shares were sold and at what price range?
The director sold 62,500 shares of Class A Common Stock at prices ranging from $30.00 to $30.005 per share.
What stock options did the Confluent (CFLT) director exercise?
The director exercised a stock option to buy 62,500 shares of Class B Common Stock at an exercise price of
How are Confluent's Class B and Class A shares related in this filing?
Each share of Class B Common Stock is convertible into one share of Class A Common Stock, including automatic conversion upon sale or transfer and optional conversion at the holder’s choice.
How many Confluent (CFLT) securities does the director hold after these transactions?
Following the reported transactions, the director directly held 28,549 shares of Class A Common Stock and 187,500 derivative securities.
Was the Confluent (CFLT) share sale made under a Rule 10b5-1 plan?
Yes. The 62,500 Class A shares were sold pursuant to a Rule 10b5-1 plan dated